Chronix Biomedical to start new disease detection.

In addition, as the Chronix technology can pinpoint particular DNA-related damage to the patient’s cells, this personalized medicine approach may make it possible to investigate each patient’s profile and then to complement those profiles to treatment outcomes. These analyses could offer rapid feedback to researchers on the most likely efficacy of treatment plans and could potentially serve as surrogate biomarkers of the efficacy of different treatments. Related StoriesStudy shows uncommon HER2 missense mutations do not spread breast cancer on the ownCornell biomedical engineers develop 'super natural killer cells' to destroy tumor cells in lymph nodesMeat-rich diet may boost kidney cancer riskThe new Chronix laboratory support is supporting the task of Dr.Therefore say cardiologists at The University of Texas M. D. Anderson Cancer Middle, who published, in the 29 problem of the journal Circulation June, the first large scale review detailing cardiovascular complications that often occur in cancers therapy, as well as ways to prevent or deal with them. The scholarly study draws on 30 years of experience at M. D. Anderson Cancer Middle as well as on the existing body of research on the cardiotoxicity of various agents.